首页> 外文期刊>European urology >Reply to Eliezer M. Van Allen, Levi A. Garraway and Jonathan E. Rosenberg's Letter to the Editor re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014
【24h】

Reply to Eliezer M. Van Allen, Levi A. Garraway and Jonathan E. Rosenberg's Letter to the Editor re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014

机译:回复Eliezer M. Van Allen,Levi A. Garraway和Jonathan E. Rosenberg致编辑的信,关于:Floris H. Groenendijk,Jeroen de Jong,Elisabeth E. Fransen van de Putte等。 ERBB2突变表征了对新辅助化学疗法有出色反应的肌肉浸润性膀胱癌亚组。 Eur Urol。在新闻。 http://dx.doi.org/10.1016/j.eururo.2015.01.014

获取原文
获取原文并翻译 | 示例
           

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号